Prof. Yi Hu 胡祎
Chief Physician, Professor
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of thoracic tumors, including breast cancer, lung cancer, esophageal cancer, mediastinal tumors, and pleural mesothelioma. Expertise includes minimally invasive thoracoscopic surgery, breast-conserving surgery, endoscopic mucosal resection for early esophageal cancer, and management of pleural effusion.
Dr. Hu studied at Sun Yat-sen University of Medical Sciences (1990–1995) and worked at Anyang Cancer Hospital (1995–2001). After earning a master’s degree from Sun Yat-sen University of Medical Sciences (2001–2004), Dr. Hu joined Sun Yat-sen University Cancer Center in 2004 while pursuing a doctoral degree. Research focuses on comprehensive treatment, staging, and minimally invasive therapy for esophageal and lung cancers.
Professional roles
- Member, Thoracic Endoscopy and Minimally Invasive Surgery Professional Committee, Endoscopy Physician Branch, Chinese Medical Doctor Association
- Member, National Evaluation Committee for Endoscopy and Minimally Invasive Surgery Technology
- Member, Chinese Medical Association
- Member, Thoracic Surgery Branch, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Hu Yi). Papers usually list the name as Yi Hu or Hu Y.
Selected publications
73 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Clin Lung Cancer, 2026 (senior author): Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study. PubMed 42586029
- Thorac Cancer, 2026 (senior author): Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis and Immunologic Insight Into Recurrence Risk. PubMed 42206574
- BMC Pulm Med, 2026 (senior author): Development and validation of a comprehensive immune-related gene signature for prognostic stratification in stage I lung adenocarcinoma. PubMed 41882682
- Ann Surg Oncol, 2025 (senior author): Comparative Analysis of Long-Term Outcomes Between Near-Infrared Fluorescence Imaging with Indocyanine Green-Guided Mediastinal Lymphadenectomy and Conventional Surgery for Esophageal Cancer. PubMed 40319209
- BMC Med Genomics, 2025 (senior author): The prognostic significance and Immunomodulatory role of SCGB3A1 expression in stage I lung adenocarcinoma. PubMed 40691840
- Ann Surg Oncol, 2024 (senior author): ASO Author Reflections: Near-Infrared Fluorescent Imaging with Indocyanine Green Facilitates Mediastinal Lymph Nodes Dissection in Esophageal Cancer Surgery. PubMed 38376708
- Ann Surg Oncol, 2024 (senior author): Comparison of Postoperative Outcomes Between Near-Infrared Fluorescent Imaging-Guided Mediastinal Lymphadenectomy and Conventional Surgery for Esophageal Cancer. PubMed 38245649
- J Thorac Dis, 2024 (senior author): Establishment and validation of a clinicopathological prediction model for postoperative recurrence of stage IA lung adenocarcinoma. PubMed 38883613
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion